CPA
Capital Performance Advisors Portfolio holdings
AUM
$510M
1-Year Est. Return
16.72%
1 Year Est. Return
+16.72%
AUM
$456M
AUM Growth
+$143M
(+46%)
Holding
285
Top Buys
| 1 | +$17.3M | |
| 2 | +$16.7M | |
| 3 | +$10.6M | |
| 4 |
Apple
AAPL
|
+$7.4M |
| 5 |
iShares Core MSCI EAFE ETF
IEFA
|
+$6.68M |
Top Sells
| 1 | +$990K | |
| 2 | +$467K | |
| 3 | +$397K | |
| 4 |
SMAR
Smartsheet Inc.
SMAR
|
+$345K |
| 5 |
PayPal
PYPL
|
+$301K |
Sector Composition
| 1 | Technology | 11.46% |
| 2 | Financials | 5.4% |
| 3 | Healthcare | 3.2% |
| 4 | Consumer Discretionary | 2.99% |
| 5 | Communication Services | 2.56% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
276
GitLab
GTLB
$7.56B
| – | – |
-3,667
|
|
||
277
Amplify Cybersecurity ETF
HACK
$2.34B
| – | – |
-5
|
|
||
278
Hewlett Packard
HPE
$30.3B
| – | – |
-11,776
|
|
||
279
Invesco
IVZ
$10.2B
| – | – |
-12,476
|
|
||
280
CarMax
KMX
$6.3B
| – | – |
-2,894
|
|
||
281
Medpace
MEDP
$14.8B
| – | – |
-715
|
|
||
282
Neurocrine Biosciences
NBIX
$13.9B
| – | – |
-1,730
|
|
||
283
UiPath
PATH
$8.2B
| – | – |
-12,429
|
|
||
|
284
PayPal
PYPL
$64.4B
| – | – |
-3,531
|
|
||
285
Invesco QQQ Trust
QQQ
$384B
| – | – |
-1,937
|
|